Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China

NCT04334330 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Brain Metastases

Interventions

DRUG: Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant

Sponsor

Sun Yat-sen University